bpc 157 regulatory status fda not approved warning As interest in weight loss medications and peptide therapies continues to grow, doctors are consumers about the risks associated with unregulated peptides that are increasingly being marketed online for weight loss BPC-157 Legal Status: FDA Regulations
Description
Your doctor may have prescribed this medicine for another reason

PMID 17474166

Additional information Competing interests The authors declare that they have no competing interests
Quality Assurance Every sterile batch produced in our 503B outsourcing facility undergoes comprehensive finished product testing before release: Appearance: Visual evaluation against established specifications

Appetite Suppression : Activation of the GLP-1 receptor in the brain can lead to a reduction in appetite and food intake, aiding in weight loss
